公司资料
Stoke Therapeutics 股价、新闻与催化剂
- 股票代码:
- STOK
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
32.29 USD (+2.83%)
收盘价
最后更新: 2026年8月21日
1.79B USD
市值
股价为何变动
As of Aug 21, 2026, STOK closed up 2.83% at $32.29. No new same-company headline was identified in the current news window.
公司概览
业务概览
Stoke Therapeutics is a genetic-medicine company focused on RNA-based approaches for severe diseases such as epilepsy. Its platform is aimed at restoring protein expression in haploinsufficient conditions.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Stoke sits in specialty biotechnology.
商业模式特征
The company depends on clinical proof, RNA platform validation, and the ability to translate genetic medicine into real value.
生物医药行业定位
Stoke is a high-beta genetic-medicine name whose valuation is closely tied to clinical progress.
未来催化剂
- Stoke Therapeutics's catalysts are zorevunersen in Dravet syndrome and its SYNGAP1 program. The next update matters because the company’s neuroscience story is still very focused.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。